medline.ch Onkologie Urologische Tumoren

	3D surgical navigation contributes to renal function preservation during robot-assisted partial nephrectomy. J Robot Surg Park MU, Suh J, Kim JK, Song C. PMID: 42201407 [PubMed - indexed for MEDLINE]
	PROQURE-I: a phase I study adding concurrent [(177)Lu]Lu-PSMA-617 to EBRT and ADT in curative intent treatment of N1 prostate cancer. Eur J Nucl Med Mol Imaging Zuur LG, Hoogenkamp DS, van der Sar ECA, van Asten D, Lam MGEH, van der Voort-van Zyp JRN, van Leeuwen PJ, de Wit-van der Veen BJ, de Vries-Huizing DMV, Hendrikx JJMA, Braat AJAT, Vogel WV. PMID: 42201380 [PubMed - as supplied by publisher]
	Beyond PSA-Can Systemic Inflammatory Indices Improve Prostate Cancer Detection? Med Sci (Basel) Iv, Shurrab A, Puia D, Iv, Corlade-Andrei M, Stoican N, Pricop C. PMID: 42201035 [PubMed - indexed for MEDLINE]
	Synchronous Prostate Adenocarcinoma and Bladder Carcinoma In Situ Detected During Evaluation of Incidental PSA Elevation: A Case Report Illustrating Multimodal Diagnostic Correlation and Long-Term Follow-Up. Reports (MDPI) Borta SM, Cri, Miklos I, Zdremtan D, Coman RA. PMID: 42200870 [PubMed]
	Rectal mucinous adenocarcinoma mimicking prostatic urothelial carcinoma: A diagnostic and therapeutic challenge. Urol Case Rep Homeniuk A, Ge R. PMID: 42200115 [PubMed]
	Diagnostic value of PRIMARY score and a combined model with SUVmax in 18F-PSMA-1007 PET/CT for prostate cancer. Front Med (Lausanne) Hu F, Li X, Li Z, Huang W, Liu W, Lian S, Liu S. PMID: 42200055 [PubMed]
	Comparative evaluation of composite inflammatory indices for predicting prostate cancer risk and mortality: a NHANES-based study with external validation. Front Oncol Chen H, Lei J, Zhang W, Wang Z, Liu R, Chen L. PMID: 42200020 [PubMed]
	Trends in the diagnosis of variant bladder cancer: a national retrospective cohort analysis. Front Oncol Rahman SN, Keervani K, Zhao X, Perry CJ, Mu P, Martin D, Tan WS, Hesse DG, Petrylak DP, Warrick J, Kumar D, Humphrey PA, Ghali F. PMID: 42200013 [PubMed]
	Integrated bulk and single-cell transcriptomics reveals TREH as a novel protective biomarker and prognostic predictor in clear cell renal cell carcinoma. Front Oncol Ma K, Wang Y, Xue X, Hu J, Li L. PMID: 42200006 [PubMed]
	Emerging Therapeutic Strategies in Metastatic Hormone-Sensitive Prostate Cancer. J Immunother Precis Oncol Castro EA, Jani YC, Bilen MA. PMID: 42199608 [PubMed]
	Cisplatin - induced peripheral neuropathy and biomarkers of gut microbial translocation in testicular germ cell tumor survivors. Front Immunol Rychtarikova D, Kalavska K, Obertova J, Palacka P, Rejlekova K, Sycova-Mila Z, Orszaghova Z, Lesko P, Alzeer R, Vasilkova L, Svetlovska D, Mladosievicova B, Pastorek M, Rychtarik M, Vlkova B, Celec P, Mego M, Chovanec M. PMID: 42199430 [PubMed - indexed for MEDLINE]
	Prioritising Data Quality Governance for AI in Prostate Cancer: A Methodological Proof-of-Concept Study Using Neural Networks for Risk Stratification. Diagnostics (Basel) Talavera-Cobo V, Robles-Garcia JE, Guillen-Grima F, Calva-Lopez A, Tapia-Tapia M, Labairu-Huerta L, Ancizu-Marckert FJ, Guillen-Aguinaga L, Sanchez-Zalabardo D, Miñana-Lopez B. PMID: 42196820 [PubMed]
	A Review of Approaches to the Synthesis of DCL-Based Prostate-Specific Membrane Antigen Ligands. Int J Mol Sci Zyk NY, Butakova NS, Machulkin AE, Beloglazkina EK. PMID: 42196616 [PubMed - indexed for MEDLINE]
	Silybum marianum-Derived Compounds in Prostate Cancer: Mechanisms of Action and Translational Potential. Int J Mol Sci Randisi F, Modoni G, Riva M, Perletti G, Odorico D, Marras E, Gariboldi MB. PMID: 42196582 [PubMed - indexed for MEDLINE]
	Natural Products in Clear Cell Renal Cell Carcinoma: Rewiring the VHL-HIF Axis, Metabolic Plasticity, and Tumor-Immune Interactions. Int J Mol Sci Tsai YC, Tsai CC, Tsai VFS, Lin CH, Kuo CY. PMID: 42196561 [PubMed - indexed for MEDLINE]
	AKT2 Exon 3 Variants and Their Prevalence in Prostate Cancer Patients: Insights from a Jordanian Clinical Cohort. Int J Mol Sci Rahahlah N, Al-Alami Z, Alorjani MS, Al-Smadi A, Obeidat S, Otoom R, Al-Zoubi RM, Al Bashir S, Al Zoubi MS. PMID: 42196210 [PubMed - indexed for MEDLINE]
	Olfactory Science and Technology in Prostate Cancer Diagnosis: From Invertebrate Models to Artificial Intelligence. Life (Basel) Hegazi MAAA, Monari MN, Pasqualini F, Beltrame S, Martella C, Bax C, Tidu L, Capelli LM, Taverna G, Grizzi F. PMID: 42195404 [PubMed]
	Enhanced Imaging in Bladder Cancer: Fluorescence Cystoscopy and Molecular Diagnostics. Life (Basel) Godlewski D, Aebisher D, Bartusik-Aebisher D, Dynarowicz K, Smolak B, Krupka-Olek M, Kawczyk-Krupka A. PMID: 42195383 [PubMed]
	Systems Biology and Multi-Omics Determinants of Response to Bladder-Preserving Trimodality Therapy in Muscle-Invasive Bladder Cancer. Life (Basel) Schi, Munteanu VC, Borz MB, Cojocaru I, Morari O, Gîrbovan M, Ti. PMID: 42195381 [PubMed]
	Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study. Medicina (Kaunas) Karakayal, Seyyar M, , , Karabu, Ate, Bacak B, Baykara M, Turhan G, Akar H, Ekinci F, Ery, Ye, Akba, Kalem A, Y, Demirdelen E, Ta, Y, Tanr, Sever N, Çabuk D, Kefeli U, Uygun K. PMID: 42195245 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 178558

Seite 1 von 8928

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung